Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA schedules circulatory devices session:

This article was originally published in Clinica

Executive Summary

The FDA will hold a meeting of its circulatory system devices advisory panel on September 21 in Gaithersburg, Maryland, to discuss clinical trial design in the evaluation of cardiopulmonary resuscitation devices and therapies. The meeting comes at a time when the American College of Cardiology is in the midst of rethinking its CPR guidelines for first responders. Recent research suggests that emergency medical personnel should conduct CPR first before using an automatic external defibrillator to treat a patient in cardiac arrest.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT059401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel